A prognostic impact of interleukin 32 (IL-32) as an immune marker in patients with bladder cancer.

Autor: ABD, Mohammed Mahdi1 biologist_mohammed@sci.utq.edu.iq, ALYASIRI, Mohammed H.2, Azeez ATIYAH, Saad Abdul3
Zdroj: Romanian Journal of Medical Practice. 2024, Vol. 19 Issue 2, p118-126. 9p.
Databáze: Academic Search Ultimate